http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_615218ad15ccf5cb9be4921e3ba0d6bb
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Beale |
| name | Philip Beale |
| given-name | Philip |
| organization-name | Sydney Catalyst Translational Cancer Research Centre University of Sydney Camperdown New South Wales Australia; Cancer Services Sydney Local Health District Sydney New South Wales Australia Concord Repatriation General Hospital, Concord West, NSW 2138, Australia University of Sydney and Royal Prince Alfred Hospital, Level 6, Gloucester House, RPAH, Missenden Road, Camperdown, NSW 2050, Australia. Electronic address: Philip.Beale@health.nsw.gov.au. Sydney Catalyst Translational Research Centre University of Sydney Camperdown New South Wales Australia; Medical Oncology Chris O'Brien Lifehouse Camperdown New South Wales Australia; Medical Oncology Concord Repatriation General Hospital Concord New South Wales Australia Cancer Services; Royal Prince Alfred Hospital; Camperdown New South Wales Australia Sydney Cancer Centre, Concord Hospital, Concord, NSW, Australia. Sydney Cancer Centre, Concord Hospital, Concord, Australia. Sydney Cancer Centre, Concord Hospital, Sydney, NSW 2139, Australia Chris O'Brien Lifehouse, Sydney, NSW, Australia. Sydney Medical School, Faculty of Medicine and Health, University of Sydney ;; Concord Cancer Centre, Concord Repatriation General Hospital, NSW, 2139 ; Concord Hospital, Sydney, NSW, Australia. From the Department of Medical Oncology, University of Ioannina, School of Medicine, Ioannina, Greece; and Cancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research, Belmont, Sutton, United Kingdom, members of the European Organization for Research and Treatment of Cancer, Early Clinical Studies Group; NDDO Oncology, Amsterdam, the Netherlands; and Department of Biological Research Biochemistry, ASTA Medica AG, Frankfurt, Germany. Medical Oncology, Royal Prince Alfred Hospital and Concord Repatriation General Hospital and Chris O’Brien Lifehouse, Sydney, NSW, Australia Faculty of Medicine, University of Sydney, Sydney;; Department of Oncology, Concord Repatriation General Hospital, Concord, New South Wales; Janette L. Vardy, Haryana M. Dhillon, Corrinne Renton, and Stephen Clarke, University of Sydney; Janette L. Vardy and Philip Beale, Concord Cancer Centre, Sydney, New South Wales, Australia; Janette L. Vardy, Anna Dodd, and Ian F. Tannock, Princess Margaret Cancer Centre, University of Toronto; Sean B. Rourke, Tsegaye Bekele, and Haibo Zhang, St Michael's Hospital, University of Toronto, Toronto; and Gregory R. Pond, McMaster University, Hamilton, Ontario, Canada. 25Concord Hospital, Sydney, New South Wales, Australia. Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Cancer Services and Palliative Care Sydney Cancer Centre Concord New South Wales Australia Department of Medical Oncology, Concord Hospital, Concord, New South Wales, Australia. Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia. Faculty of Medicine, University of Sydney, Camperdown, New South Wales, Australia. Concord Clinical School, Faculty of Medicine and Health, University of Sydney , Sydney, NSW 2137 , Australia Sydney Cancer Centre, Concord Repatriation Hospital, Concord, NSW, Australia. |
Incoming Links
Total number of triples: 134.